135 Trademark Results found for "POWR-MOP"

Also try searching for:

POWR-MOP*

POWR*

*MOP

PO*OP

Details	Status	Class/Description
MOP MOP MUSICAL PRODUCTS LTD. 451550 20 Mar 1980	EXPUNGED on 10 May 1996	Metronomes. Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Metronomes.
AI-POWR HEPION PHARMACEUTICALS INC. 2116176 29 Dec 2020	ABANDONED SECTION 36 on 25 Jul 2023	Computer software for using artificial intelligence, machine learning,... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computer software for using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field; computer software for integrating artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation with disease studies and investigations, pharmaceutical and drug research and development, biomedical, biological, and biotechnological research and development, and pharmacology, clinical pharmacology, system pharmacology, and system biology; computer software for clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; computer software for patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; computer software for drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, accessing, processing, and analyzing public and proprietary omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data via a global computer network using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; computer software for disease studies and investigations, understanding of diseases, pharmaceutical and drug research and development, biomedical, biological, and biotechnological research and development, and pharmacology, clinical pharmacology, system pharmacology, system biology research and development using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation. Class 042 Class 042 Computer & Software Services & Scientific Services Design, development, programming, testing, maintenance, customization, and operation of computer software in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; consulting, consultancy, and consulting services related to clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and related to the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); platform as a service (PaaS) featuring computer platforms and software for using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field; software as a service (SaaS) featuring computer platforms for using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field; research and development in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; performing clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and services in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation for others (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations).
POWR-GRIP WOOD'S POWR-GRIP CO. INC. 1540855 23 Aug 2011	REGISTERED on 11 Jun 2015	Lifting apparatus, namely, hand-operated suction lifters; lifting appa... Class 007 Class 007 Machinery Products Lifting apparatus, namely, hand-operated suction lifters; lifting apparatus, namely, lifting jacks, lifting cables; machines for industrial use, namely, machines for processing, transport, and assembly and fixing of glass, namely, glass panes, namely, glass cutting machines, machine tools for glass; lamination machines; machines for fixing glass panes in position whilst being glued; machines being installation aids for glass panes; machines in the form of magnetic holders and suction holders for glass panes; machines for lifting and transporting glass planes, plastics, metal sheets, tiles, marble and parts of these goods; hand tools implements (hand-operated) for the processing, lifting, assembly and transporting of glass panes and parts for these goods; hand-operated suction lifters and suction holders; hand tools and implements (hand operated), for fixing glass panes in position whilst being glued; hand tools and implements (hand operated) being installation aids, hand tools and implements (hand-operated) in the form of magnetic holders and suction holders; suction lifters; manual apparatus for lifting and transporting glass panes, plastics, metal sheets, tiles, marble and parts of these goods, hand tools and implements (hand-operated) namely for glass, floor and tile laying, hand-operated gluing apparatus, namely, glue gun; hand tools and implements (hand-operated) for the processing, transport, assembly and mounting of glass, namely glass panes; hand tools and implements (hand-operated) for cutting glass; hand tools and implements (hand-operated) for fixing glass panes by means of adhesion; hand tools and implements (hand-operated) being mounting aids, excluding tools, namely, pliers and power tools. Class 008 Class 008 Hand Tool Products ... Class 019 Non-Metallic Building Material Products
POWR-CENTER GENERAL CABLE TECHNOLOGIES CORPORATION 1180678 9 Jun 2003	EXPUNGED on 24 Sept 2020	Extension cords. Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Extension cords.
EN-POWR PANASONIC CANADA INC. 852660 1 Aug 1997	ABANDONED SECTION 40(3) on 23 Aug 2000	Synthesized numeric display pagers. Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Synthesized numeric display pagers.
POWR-CLOR CALGON VESTAL INC. (A DELAWARE CORPORATION) 788572 26 Jul 1995	EXPUNGED	Chlorinated liquid detergent for use in machine dishwashing in restaur... Class 003 Class 003 Cosmetics and Cleaning Products Chlorinated liquid detergent for use in machine dishwashing in restaurants, institutions and the like.
POWR-CENTER CAROL CABLE COMPANY INC. 601322 22 Feb 1988	ABANDONED on 27 Apr 1989	Extension cords. Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Extension cords.
POWR-CLOSER HARROW PRODUCTS INC. 542082 16 May 1985	EXPUNGED	Rotary hydraulic door closers. Class 007 Class 007 Machinery Products Rotary hydraulic door closers.
POWR/DOOR CANADIAN GENERAL ELECTRIC COMPANY LIMITED 356581 29 Aug 1972	EXPUNGED on 17 Aug 1988	Luminaires. Class 011 Class 011 Environmental Control Instrument Products lighting heating cooling cooking Luminaires.
POWR-LOK VARTA BATTERIE AKTIENGESELLSCHAFT 300755 10 Nov 1966	EXPUNGED on 4 Nov 1982	Batteries. Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Batteries.

EXPUNGED

on 10 May 1996

MOP

MOP MUSICAL PRODUCTS LTD.

451550 · 20 Mar 1980

009

Metronomes.

ABANDONED SECTION 36

on 25 Jul 2023

AI-POWR

HEPION PHARMACEUTICALS INC.

2116176 · 29 Dec 2020

009

Class 009

Computer & Software Products & Electrical & Scientific Products

Computer software for using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field; computer software for integrating artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation with disease studies and investigations, pharmaceutical and drug research and development, biomedical, biological, and biotechnological research and development, and pharmacology, clinical pharmacology, system pharmacology, and system biology; computer software for clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; computer software for patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; computer software for drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, accessing, processing, and analyzing public and proprietary omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data via a global computer network using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; computer software for disease studies and investigations, understanding of diseases, pharmaceutical and drug research and development, biomedical, biological, and biotechnological research and development, and pharmacology, clinical pharmacology, system pharmacology, system biology research and development using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation.

042

Class 042

Computer & Software Services & Scientific Services

Design, development, programming, testing, maintenance, customization, and operation of computer software in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; consulting, consultancy, and consulting services related to clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and related to the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); platform as a service (PaaS) featuring computer platforms and software for using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field; software as a service (SaaS) featuring computer platforms for using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field; research and development in clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation; performing clinical trials or studies, designing clinical trials or studies, enriching and enhancing clinical trial or study designs, de-risking clinical trial or study designs, clinical trials simulations, clinical endpoint selection, analyzing non-clinical data, preclinical data, and clinical data, analyzing results of clinical trials or studies, and evaluating clinical outcomes and treatment responses, patient identification and a priori responder selection, individualizing treatments, predicting clinical outcomes and treatment responses, and disease diagnoses and treatment determination, selection, and identification, drug, drug target, and drug combination selection and evaluation, biomarker selection, genetic analyses, omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics analyses, and accessing, processing, and analyzing omics, multiomics, genomics, transcriptomics, proteomics, lipidomics, and metabolomics data, and services in the medical field, biomedical field, healthcare field, pharmaceutical field, and biotechnological field using artificial intelligence, machine learning, supervised machine learning, unsupervised machine learning, deep learning, statistical learning, data mining, big data analytics, predictive analytics, predictive modeling, multivariate analytics, precision medicine, bioinformatics, modeling, and simulation for others (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations).

Computer software for using artificial intelligence, machine learning,...

REGISTERED

on 11 Jun 2015

POWR-GRIP

WOOD'S POWR-GRIP CO. INC.

1540855 · 23 Aug 2011

007

008

...

Lifting apparatus, namely, hand-operated suction lifters; lifting appa...

EXPUNGED

on 24 Sept 2020

POWR-CENTER

GENERAL CABLE TECHNOLOGIES CORPORATION

1180678 · 9 Jun 2003

009

Extension cords.

ABANDONED SECTION 40(3)

on 23 Aug 2000

EN-POWR

PANASONIC CANADA INC.

852660 · 1 Aug 1997

009

Synthesized numeric display pagers.

EXPUNGED

POWR-CLOR

CALGON VESTAL INC. (A DELAWARE CORPORATION)

788572 · 26 Jul 1995

003

Chlorinated liquid detergent for use in machine dishwashing in restaur...

ABANDONED

on 27 Apr 1989

POWR-CENTER

CAROL CABLE COMPANY INC.

601322 · 22 Feb 1988

009

Extension cords.

EXPUNGED

POWR-CLOSER

HARROW PRODUCTS INC.

542082 · 16 May 1985

007

Rotary hydraulic door closers.

EXPUNGED

on 17 Aug 1988

POWR/DOOR

CANADIAN GENERAL ELECTRIC COMPANY LIMITED

356581 · 29 Aug 1972

011

Luminaires.

EXPUNGED

on 4 Nov 1982

POWR-LOK

VARTA BATTERIE AKTIENGESELLSCHAFT

300755 · 10 Nov 1966

009

Batteries.

Owners

Tacony corporation (8)

Home hardware stores limited (5)

Reckitt benckiser (canada) inc. (5)

The procter & gamble company (4)

Thane ip limited (4)

Freudenberg household products inc. faisant également affaires sous les dénominations produits ménagers freudenberg inc. ou fhp inc. (3)

The libman company (3)

Bissell inc. (2)

Lg electronics inc. (2)

Mf distributions inc. (2)